Olanzapine long-acting injection: a review of first experiences of post-injection delirium/sedation syndrome in routine clinical practice

BACKGROUND: Olanzapine long-acting injection (LAI) for the treatment of schizophrenia was associated with a cluster of symptoms termed post-injection delirium/sedation syndrome (PDSS) in a small percentage (~2%) of patients during clinical trials. The objective of this analysis was to evaluate the r...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:BMC Psychiatry
Päätekijät: Bushe, Chris J, Falk, Deborah, Anand, Ernie, Casillas, Marta, Perrin, Elena, Chhabra-Khanna, Rashna, Detke, Holland C
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2015
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4389990/
https://ncbi.nlm.nih.gov/pubmed/25886006
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12888-015-0450-9
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia